Hyperuricemia is associated with progression of IgA nephropathy

International Urology and Nephrology

Volumn 47, Issue 4, 2015, Pages 673-678

  Bakan, Ali ^a   Oral, Alihan ^a   Elcioglu, Omer Celal ^a   Takir, Mumtaz ^a   Kostek, Osman ^a   Ozkok, Abdullah ^a   Basci, Semih ^a   Sumnu, Abdullah ^b   Ozturk, Savas ^c   Sipahioglu, Murat ^d   Turkmen, Aydın ^e   Voroneanu, Luminita ^f   Covic, Adrian ^f   Kanbay, Mehmet ^g  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d ERCIYES UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^g KOÇ UNIVERSITY   (Turkey)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Hyperuricemia; IgA nephropathy

Indexed keywords

BIOLOGICAL MARKER; URIC ACID;

ADULT; BLOOD; COMPLICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIOMARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERURICEMIA; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; URIC ACID;

EID: 84939961212     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-015-0939-7     Document Type: Article

References (22)

1. Cheng GY, Liu DW, Zhang N, Tang L, Zhao ZZ, Liu ZS (2013) Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up. Clin Nephrol 80:40–46
2. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP (1997) Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199–207
3. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759–766
4. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A (2007) Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol 39:1227–1233
5. Shi Y, Chen W, Jalal D, Li Z, Chen W, Mao H, Yang Q, Johnson RJ, Yu X (2012) Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res 35:153–160
6. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M (2001) Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87:333–339
7. Myllymaki J, Honkanen T, Syrjanen J, Helin H, Rantala I, Pastenack A, Pastenack A, Mustonen J (2005) Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 20:89–95
8. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ (2011) A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 6:1887–1894
9. Rich MW (2000) Uric acid: Is it a risk factor for cardiovascular disease? Am J Cardiol 85:1018–1021
10. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:991–997
11. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13:2888–2897
12. Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, Sanchez-Lozada LG, Gersch M, Rodriguez-Iturbe B, Kang DH, Acosta JH (2005) Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link? J Am Soc Nephrol 16:1909–1919
13. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ (2005) Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 25:425–433
14. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system. J Hypertens 26(2):269–275
15. Tomino Y (2008) IgA nephropathy: lessons from an animal model, the ddY mouse. J Nephrol 21:463–467
16. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, Nakagawa T, Johnson RJ (2006) Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol 17:165–168
17. Barberi S, Menè P (2006) Role of uric acid in hypertension and in the progression of chronic renal disease. G Ital Nefrol 23:4–11
18. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P, Cheepudomwit S, Yipintsoi T (2005) Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 16:791–799
19. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5:1388–1393
20. Zhou J, Chen Y, Liu Y, Shi S, Li X, Wang S, Zhang H (2014) Plasma uric acid level indicates tubular interstitial lesions at early stage of IgA nephropathy. BMC Nephrol 15:11
21. Nasri H, Baradaran A (2014) Aggravation of immunoglobulin a nephropathy by hyperuricemia: a mini-review on current findings and new concepts. Iran J Kidney Dis 8:359–362
22. Ohno I (2011) Relationship between hyperuricemia and chronic kidney disease. Nucleosides Nucleotides Nucleic Acids 30(12):1039–1044. doi:10.1080/15257770.2011.611484